Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Jeffrey Radding

Feb 15, 2007
Premium
Jeffrey Radding has joined Epitome Biosystems as vice president for research and development, the company announced this week.
 
Prior to joining Epitome, Radding headed the Platform Biology Group at Eli Lilly. The group evaluated and implemented cell signaling approaches for drug discovery across multiple therapeutic areas.
 
Radding obtained his PhD in chemistry from Indiana University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Treatment for Rapid Aging

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

AstraZeneca, Oxford Announce Results Suggesting High Efficacy of Vaccine

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

Criticism Leads to Review of Paper

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

PLOS Papers on SARS-CoV-2 Phylogenies, Swiss Influenza Spread, Infant Meningitis in Ethiopia

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.

What's Popular?

In Proteomics & Protein Research

  1. Correlia Biosystems Closes $7M Series A Round

  2. New NGS-Based Tissue Analysis Method Offers Spatial Detail on Transcriptome, Proteins

    Premium

  3. Proteogenomic Analysis Uncovers New Breast Cancer Subtypes, Suggests Treatment Options

  4. IsoPlexis Targets New Market Segments With Cheaper, More Flexible Single-Cell Proteomic Systems

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.